title: [Clinical and epidemiological aspects and current recommendations on treatment of genital herpes].
authors.forename: V V
authors.initials: VV
authors.lastname: Glad'ko
authors.forename: V A
authors.initials: VA
authors.lastname: Akovbian
authors.forename: S A
authors.initials: SA
authors.lastname: Masiukova
authors.forename: A B
authors.initials: AB
authors.lastname: Zudin
authors.forename: O V
authors.initials: OV
authors.lastname: Glad'ko
authors.forename: Iu S
authors.initials: IuS
authors.lastname: Egorova
authors.forename: M Kh
authors.initials: MKh
authors.lastname: Omarova
mesh_terms: D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000547:Amantadine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077595:Famciclovir; D005260:Female; D006287:Health Planning Guidelines; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008887:Military Medicine; D008889:Military Personnel; D012426:Russia / Q000453:epidemiology; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D015075:2-Aminopurine; D000547:Amantadine; C004279:tromantadine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir